Current updates on generations, approvals, and clinical trials of CAR T-cell therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Current updates on generations, approvals, and clinical trials of CAR T-cell therapy

Published:2022-09-12 Issue:6 Volume:18 Page:
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Asmamaw Dejenie Tadesse¹,Tiruneh G/Medhin Markeshaw¹,Dessie Terefe Gashaw¹,Tadele Admasu Fitalew²,Wale Tesega Wondwossen³,Chekol Abebe Endeshaw²

Affiliation:

1. Department of Biochemistry, School of Medicine, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia

2. Department of Biochemistry, College of Medicine and Health Science Arbaminch University, Arbaminch, Ethiopia

3. Department of Biochemistry, College of Health Sciences, Debre Tabor University, Debre Tabor, Ethiopia

Funder

no funding

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/21645515.2022.2114254

Reference248 articles.

1. Adoptive T Cell Immunotherapy For Cancer

2. Does the Immune System See Tumors as Foreign or Self?

3. Human tumor antigens recognized by T cells

4. Chimeric Antigen Receptor–Engineered T Cell Therapy in Lymphoma

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancements in tumor-infiltrating lymphocytes: Historical insights, contemporary milestones, and future directions in oncology therapy;Critical Reviews in Oncology/Hematology;2024-10

2. Pre-Clinical Models for CAR T-Cell Therapy for Glioma;Cells;2024-09-04

3. Antigen escape in CAR-T cell therapy: Mechanisms and overcoming strategies;Biomedicine & Pharmacotherapy;2024-09

4. The Current Landscape of Secondary Malignancies after CAR T-Cell Therapies: How Could Malignancies Be Prevented?;International Journal of Molecular Sciences;2024-09-01

5. Current Insights into CAR T-Cell-Based Therapies for Myelodysplastic Syndrome;Pharmaceutical Research;2024-08-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3